ASX:VLS Vita Life Sciences (VLS) Stock Price, News & Analysis → Central Bank Gold Heist In Progress (From Colonial Metals) (Ad) Free VLS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2,815 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield3.83%Price TargetN/A Stock AnalysisStock Analysis Get Vita Life Sciences alerts: Email Address Ad Crypto 101 MediaLike Tiny Crypto Retirement FundsThe crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. Click here and see how to get a copy. About Vita Life SciencesVita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidant; and bones and joints. The company markets its products through pharmacies and health food channels under the Herbs of Gold and VitaHealth brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.Read More Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. VLS Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive VLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vita Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:VLS CUSIPN/A CIKN/A Webwww.vitalifesciences.com Phone61 3 9828 0500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.17 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$9.08 million Net Margins12.24% Pretax MarginN/A Return on Equity22.74% Return on Assets13.29% Debt Debt-to-Equity Ratio0.89 Current Ratio2.98 Quick Ratio1.57 Sales & Book Value Annual Sales$74.16 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.62 Book ValueA$0.77 per share Price / BookN/AMiscellaneous Outstanding Shares56,400,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.42 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Andrew W. O'KeefeMD & DirectorMr. Chin Leng Khoo AGIAC.A., C.P.A., M.B.A., CFO, Company Secretary & Acting CEO of Asia RegionMs. Melissa PereiraGroup Marketing Manager (Leave of Absence)Mr. Shaun RutherfordChief Executive Officer of Herbs of Gold ANZMs. June LauGeneral Manager of Operations & Business SupportAlexandra WardTechnical & NPD ManagerMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All CompetitorsInsidersPeter OsborneBought 10,000 shares on 3/12/2024Total: $22,500.00 ($2.25/share)Henry TownsingSold 102,594 sharesTotal: $183,643.26 ($1.79/share)Peter OsborneBought 6,700 shares on 10/27/2023Total: $11,591.00 ($1.73/share)Peter OsborneBought 8,574 shares on 10/25/2023Total: $14,815.87 ($1.73/share) VLS Stock Analysis - Frequently Asked Questions How often does Vita Life Sciences pay dividends? What is the dividend yield for Vita Life Sciences? Vita Life Sciences announced a Interim dividend on Tuesday, September 19th. Stockholders of record on Thursday, October 5th will be given a dividend of 0.03 per share on Thursday, October 5th. This represents a dividend yield of 1.78%. The ex-dividend date is Thursday, September 21st. This is a positive change from the stock's previous Interim dividend of A$0.03. Read our dividend analysis for VLS. Is Vita Life Sciences a good dividend stock? Vita Life Sciences (ASX:VLS) pays an annual dividend of A$0.09 per share and currently has a dividend yield of 3.83%. The dividend payout ratio is 52.94%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for VLS. This page (ASX:VLS) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vita Life Sciences Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.